Holen Sie sich die Stockscreener-App
108.88
0.32%
-0.35
Handel nachbörslich:
108.88
Glaukos Corporation Aktie (GKOS) Neueste Nachrichten
Citigroup Maintains Glaukos (GKOS) Buy Recommendation - Nasdaq
FDA approves Glaukos’ Epioxa as incision-free corneal disease treatment - MSN
GKOS: Citigroup Raises Glaukos Price Target to $125, Maintains B - GuruFocus
Glaukos price target raised to $125 from $113 at Citi - TipRanks
Glaukos stock price target raised to $125 from $117 at Needham By Investing.com - Investing.com South Africa
Needham Raises Price Target for GKOS, Maintains Buy Rating | GKO - GuruFocus
Trading the Move, Not the Narrative: (GKOS) Edition - news.stocktradersdaily.com
Glaukos price target raised to $125 from $117 at Needham - TipRanks
Needham Adjusts Glaukos Price Target to $125 From $117, Maintains Buy Rating - marketscreener.com
Glaukos stock price target raised to $125 from $117 at Needham - Investing.com India
Marshall Wace LLP Sells 114,086 Shares of Glaukos Corporation $GKOS - MarketBeat
Divisadero Street Capital Management LP Invests $10.51 Million in Glaukos Corporation $GKOS - MarketBeat
Glaukos (NYSE:GKOS) shareholders have earned a 34% CAGR over the last three years - Yahoo Finance
What market sentiment indicators show for Glaukos Corporation stockJuly 2025 Trends & Community Consensus Trade Alerts - Newser
Can Glaukos Corporation stock attract analyst upgradesJuly 2025 Closing Moves & Scalable Portfolio Growth Ideas - Newser
Norges Bank Takes $76.31 Million Position in Glaukos Corporation $GKOS - MarketBeat
Glaukos Corporation $GKOS Shares Sold by Brown Capital Management LLC - MarketBeat
Glaukos Corporation Stock Analysis and ForecastMACD Trading Signals & Rapid Portfolio Expansion - earlytimes.in
Why Glaukos Corporation stock appears on watchlistsWeekly Trade Review & Daily Chart Pattern Signal Reports - Newser
Will Glaukos Corporation (6GJ) stock remain on Wall Street radarJuly 2025 EndofMonth & Precise Entry and Exit Recommendations - Newser
Can Glaukos Corporation (6GJ) stock double in coming yearsForecast Cut & Free Weekly Chart Analysis and Trade Guides - Newser
Is Glaukos Corporation stock a top hedge fund pick2025 Support & Resistance & Short-Term High Return Ideas - Newser
Transcript : Glaukos Corporation Presents at Citi Annual Global Healthcare Conference 2025, Dec-03-2025 01 - marketscreener.com
Granite Investment Partners LLC Has $19.89 Million Stake in Glaukos Corporation $GKOS - MarketBeat
How higher bond yields impact Glaukos Corporation stockMarket Performance Report & High Accuracy Trade Alerts - Newser
Will Glaukos Corporation (6GJ) stock profit from automation waveBreakout Watch & Safe Capital Investment Plans - Newser
Here's Why You Should Retain Glaukos Stock in Your Portfolio - Your Wyoming Link
New York State Common Retirement Fund Increases Stock Position in Glaukos Corporation $GKOS - MarketBeat
Can Glaukos Corporation stock stage a strong rebound this quarter2025 Valuation Update & Fast Exit Strategy with Risk Control - Newser
Glaukos Corporation $GKOS Shares Purchased by Prudential Financial Inc. - MarketBeat
JPMorgan Chase & Co. Buys 59,389 Shares of Glaukos Corporation $GKOS - MarketBeat
Glaukos Corporation $GKOS Shares Sold by Loomis Sayles & Co. L P - MarketBeat
Legal & General Group Plc Boosts Holdings in Glaukos Corporation $GKOS - MarketBeat
Glaukos Corporation $GKOS Shares Purchased by Rhumbline Advisers - MarketBeat
Will Glaukos Corporation stock gain from government policies2025 Investor Takeaways & Entry and Exit Point Strategies - BỘ NỘI VỤ
Glaukos (GKOS) Up 20% Since Last Earnings Report: Can It Continue? - Yahoo Finance
(GKOS) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Handelsbanken Fonder AB Reduces Holdings in Glaukos Corporation $GKOS - MarketBeat
Creative Planning Has $1.90 Million Stock Holdings in Glaukos Corporation $GKOS - MarketBeat
Glaukos Corporation $GKOS Shares Purchased by Atika Capital Management LLC - MarketBeat
Alex Thurman Sells 315 Shares of Glaukos (NYSE:GKOS) Stock - MarketBeat
Why Glaukos (GKOS) Is Up 13.9% After iDose Tops Forecasts and 2025 Outlook Rises - simplywall.st
Stifel Nicolaus Sticks to Their Buy Rating for Glaukos (GKOS) - The Globe and Mail
Glaukos Corporation $GKOS Shares Bought by Ensign Peak Advisors Inc - MarketBeat
Stifel reiterates Buy rating on Glaukos stock, maintains $115 price target - Investing.com Canada
Stifel reiterates Buy rating on Glaukos stock, maintains $115 price target By Investing.com - Investing.com South Africa
Why Glaukos Shares Are Facing a Downturn - TipRanks
Glaukos President & COO Joseph Gilliam Sells 39% Of Holding - simplywall.st
Glaukos outlines $600M–$620M 2026 revenue outlook as Epioxa launch and iDose TR drive growth - MSN
FY2025 EPS Estimates for Glaukos Boosted by Zacks Research - MarketBeat
Is Glaukos Corporation stock a safe buy before earningsTrade Risk Assessment & Low Drawdown Investment Ideas - newser.com
Investors Appear Satisfied With Glaukos Corporation's (NYSE:GKOS) Prospects As Shares Rocket 25% - simplywall.st
Will Glaukos Corporation stock benefit from infrastructure spendingWeekly Trading Summary & Daily Profit Focused Stock Screening - newser.com
0.52%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):